Drug company Evotec has taken 16,823 sq ft of additional space at Milton Park, making it one of the largest occupiers there.
The firm now has 192,745 sq ft at 90 Park Drive.
Christophe Muller who manages the firm’s Milton Park site, said: “Milton Park is an integral part of Evotec’s history and, more than ever, its future.
“The current expansion has been driven by an increased demand of our high-end drug discovery services, specifically in the areas of biological and protein sciences.
“The additional footprint in bespoke facilities on Milton Park, as well as the recruitment of scientific experts, is also part of our plans to develop a fully integrated platform and centre of excellence for structure-based drug discovery in the UK.”
Philip Campbell, commercial director for Milton Park landlord MEPC said: “What started as an Oxford University spin-out 30 years ago in a small depot has grown to become one of our largest occupiers employing approximately 600 people, as well as many others around the world.
“They are a great success story and we are really proud to be able to support them in their continued quest for drug discovery alliances and innovation across many disease areas which have significant impacts for people across the globe.”
The terms of the deal are undisclosed.
Image (l-r): Christophe Muller, Evotec and Philip Campbell, Milton Park.
© Thames Tap No 225 (powered by ukpropertyforums.com).
Please rate this article out of five stars below. You can comment too, using the form at the bottom of the page.
